Susquehanna International Group, LLP Bioventus Inc. Transaction History
Susquehanna International Group, LLP
- $560 Billion
- Q3 2024
A detailed history of Susquehanna International Group, LLP transactions in Bioventus Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 83,000 shares of BVS stock, worth $815,890. This represents 0.0% of its overall portfolio holdings.
Number of Shares
83,000
Previous 109,301
24.06%
Holding current value
$815,890
Previous $628,000
57.8%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding BVS
# of Institutions
141Shares Held
45.8MCall Options Held
179KPut Options Held
124K-
Essex Woodlands Management, Inc. The Woodlands, TX13MShares$128 Million44.65% of portfolio
-
Juniper Investment Company, LLC New York, NY6.94MShares$68.2 Million33.68% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.35MShares$42.8 Million3.09% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$23.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.07MShares$20.4 Million0.0% of portfolio
About Bioventus Inc.
- Ticker BVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 61,664,200
- Market Cap $606M
- Description
- Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...